News Daily News Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats Todd Neale July 31, 2020
News Daily News ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes L.A. McKeown July 27, 2020
News Daily News Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI L.A. McKeown June 16, 2020
News Daily News TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data Michael O'Riordan June 01, 2020
News Daily News Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves Michael O'Riordan May 27, 2020
News Daily News Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes Todd Neale February 18, 2020
News Daily News Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion Yael L. Maxwell February 14, 2020
News Daily News Some Benefits Seen for TAVR Over SAVR in Cancer Patients, as Use Grows Todd Neale January 29, 2020
News Daily News Routine Anticoagulation Seems Warranted After TMVR: Review Todd Neale December 04, 2019
News Daily News PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’ Shelley Wood October 08, 2019
News Daily News MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves Michael O'Riordan August 29, 2019
News Daily News FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System Michael O'Riordan August 22, 2019
News Daily News RAS Inhibition After TAVR Gains More Support, but RCT Still Needed Todd Neale July 29, 2019
News Daily News Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites Michael O'Riordan July 17, 2019
News Daily News Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access Michael O'Riordan July 10, 2019
News Daily News FDA Approves Lotus Edge, Ushering Third Device Into US Market Shelley Wood April 24, 2019
News Daily News Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration? Michael O'Riordan March 13, 2019
News Daily News Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing Yael L. Maxwell March 01, 2019